Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal JUPITER Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
Anshar Saud
Fakultas Farmasi, Universitas Hasanuddin, Makassar
Biochemistry, Genetics & Molecular Biology Chemistry Education Health Professions Immunology & microbiology Library & Information Science Medicine & Pharmacology Public Health

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

 1 
Pengantar Editorial Seperlima Abad Jurnal Ilmu Perpustakaan, Informasi dan Komputer (JUPITER) Universitas Hasanuddin JUPITER, JURNAL; Saud, Anshar
JUPITER Vol. 18 No. 1 (2023): JUPITER
Publisher : UPT Perpustakaaan Universitas Hasanuddin

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Sungguh merupakan hal yang patut disyukuri bahwa JUPITER Unhas telah memasuki usianya yang ke-20 tahun. Edisi versi cetak dimulai sejak Agustus 2003, dan versi online dirilis pada tahun 2014. Alhamdulillah bertahan hingga hari ini. Banyak tantangan yang dilalui dan diatasi sejak berdirinya, termasuk adanya beberapa volume yang tidak terbit, disebabkan karena naskah masuk bermutu yang kurang dan adanya periode kevakuman pengurus. Namun tim editorial selalu berupaya maksimal untuk mememecahkan masalah ini, diantaranya dengan aktif menyosialisasikan Jurnal JUPITER kepada kolega serta senantiasa memupuk semangat tim untuk melanjutkannya. Selamat kepada JUPITER Unhas untuk usianya yang telah mencapai titik seperlima abad. Usia yang sudah cukup matang untuk menjadi lebih baik dari sebelumnya, semakin berkualitas dan menarik, serta menebar manfaat dan inspirasi. Semoga jurnal JUPITER kebanggaan kita ini selalu relevan untuk menjadi salah satu jurnal andalan di Universitas Hasanuddin yang ikut mewarnai dunia kepustakawanan di Indonesia. Makassar, 1 Desember 2023 Anshar Saud Chief Editor JUPITER Universitas Hasanuddin
Cost-Effectiveness Analysis of Antibiotic Therapy for Community-Acquired Pneumonia at Mimika Regional Hospital, Central Papua Arifin, Bustanul; Sattu, Fidel Yoel Junovray; Saud, Anshar
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 15, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.98701

Abstract

Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide, affecting the lower respiratory tract. It is caused by diverse pathogens, including bacteria, viruses, fungi, and chemical exposures. Antibiotics, such as ceftriaxone, are widely used for treatment. However, the high economic burden associated with CAP management necessitates a cost-effectiveness analysis to optimize treatment strategies.Objectives: This study aimed to evaluate the cost-effectiveness of three antibiotic regimens—co-amoxiclav, meropenem + levofloxacin, and ceftriaxone—for CAP inpatients at Mimika Hospital, Indonesia, to identify the most efficient therapeutic option.Methods: A retrospective, cross-sectional observational study was conducted using medical records of CAP patients admitted to Mimika Hospital between January and December 2021. Inclusion criteria were patients aged ≥18 years who received a single antibiotic regimen. Treatment effectiveness was assessed based on hospitalization duration (≤3 days) and physician-reported recovery. Cost-effectiveness was evaluated using the Average Cost-Effectiveness Ratio (ACER).Results: A total of 120 pneumonia inpatients were analyzed, predominantly male (60%) and aged 26–45 years (34%). The most frequently administered antibiotic was ceftriaxone (51%), followed by co-amoxiclav (29%) and meropenem + levofloxacin (20%). Co-amoxiclav demonstrated the highest clinical effectiveness (88.57%) and the lowest median total cost (IDR 2,696,114), resulting in the lowest ACER value (IDR 2,696,114/effectiveness unit) and a dominant ICER status. In contrast, meropenem + levofloxacin showed moderate effectiveness (75%) at the highest cost (IDR 3,088,961), with an ICER of IDR 18,538.64. Ceftriaxone had the lowest effectiveness (65.57%) and the highest ACER (IDR 44.443,22), indicating poor cost-efficiency. These findings position co-amoxiclav as the most cost-effective regimen across both clinical and economic parameters.Conclusion: Co-amoxiclav is the most cost-effective antibiotic regimen for CAP inpatients at Mimika Hospital, offering optimal therapeutic outcomes at a lower cost. These findings support its recommendation as the first-line treatment for CAP in similar healthcare settings
Review: Farmasi Sosial dan Administratif: Review: Social and Administrative Pharmacy Saud, Anshar
Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) Vol. 5 No. 1 (2019): (March 2019)
Publisher : Universitas Tadulako

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (710.246 KB) | DOI: 10.22487/j24428744.2019.v5.i1.12068

Abstract

In the health care system, pharmaceutical care systems are one of the core components and pharmacists play a very important role. With the dynamic changes that occur in health services, diseases, communication and regulatory information technology, the roles and responsibilities of pharmacists are becoming increasingly important than before. Pharmacists are dedicated and in a strategic position to maintain and advance public health. Their efforts improve the quality of life of individuals by helping people to live as freely as possible from illness, pain, and suffering. One of the obligations of pharmacists is to educate the public about health and drug use. Pharmacy practices involve pharmacists, patients, other professional health personnel and the public can be conceptualized as a social process. Therefore, understanding the concepts and principles behind social pharmacy disciplines is very essential and useful for a pharmacist and pharmacy student. The purpose of this article review is to briefly review a number of important topics concerning social, behavioral and administrative aspects in pharmacy to achieve a stronger understanding of dynamic and complex interactions between patients, pharmacists, drugs, teams of health workers, organizations and larger social systems. Mastery of students and pharmacists on this issue – asa consequence of the inclusion of social and administrative aspects into the pharmacy's higher education curriculum–willenable them to be professionally responsible for improving patient drug therapy outcomes as individuals, communities, society, and state systems; and have a greater impact on population health through drug-related public policies.
A Cost-Effectiveness Study of Antibiotic Drug Delivery System in Chronic Suppurative Otitis Media (CSOM) Akram, Muhammad; Saud, Anshar; Arifin, Bustanul
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 15, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.97985

Abstract

Background: Chronic Suppurative Otitis Media (CSOM) is a chronic inflammatory and infectious disease of the middle ear or mastoid cavity that can result in the loss of bodily functions or even death. The higher concentration of CSOM is found in developing nations such as Indonesia, where the population cannot afford treatment. In cases of persistent otorrhea following 3 weeks of treatment with topical ear antibiotics, oral antibiotics may be considered as a second line of treatment. Topical ear antibiotics are insufficiently available at healthcare facilities because they are not included in the Indonesian National List of Essential Medicines (NLEM).Objectives: The objective of this study was to compare the cost-effectiveness of topical ear antibiotics versus oral antibiotics in the treatment of chronic suppurative otitis media (CSOM).Methods: This study was a cross-sectional study using retrospective data from medical records and cost assessments at a rural hospital in the Gowa district of South Sulawesi. The effectiveness of the treatments was evaluated based on the frequency of visits to the ENT department, with antibiotic prescriptions and positive otorrhea.Results: The findings revealed that the Average Cost-Effectiveness Ratio (ACER) for topical ear antibiotics was Rp 161,020, while the ACER for oral antibiotics was Rp 286,968. The Incremental Cost-Effectiveness Ratio (ICER) was determined to be Rp 351, and the Incremental Net Benefit (INB) was positive (Rp 99,857) at threshold Rp 434,500.Conclusion: Our study found that topical ear antibiotics were more cost-effective than oral antibiotics when considering the INB values based on INA-CBGs, along with fluctuations in cost-effectiveness using sensitivity analysis.
Co-Authors Bustanul Arifin JUPITER, JURNAL Muhammad Akram Sattu, Fidel Yoel Junovray